Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Hologic Inc Add to portfolio

INX:HOLX, Apr 26, 04:28 UTC

Latest INX:HOLX News

Filter your feed

Apply Filter

Yesterday


News

Hologic Launches Trident® HD Specimen Radiography System in United States, Canada and Europe

HOLX

Hologic, Inc. (Nasdaq: HOLX) today announced global commercial availability of the Trident® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.1. The new Trident HD system, which recently received FDA clearance in the US and a CE Mark in Europe, also features a bigger detector that allows for complete imaging of larger breast surgical specimens, along with a wide range of surgical and biopsy samples.2. “The Trident HD system is a breakthrough solution that delivers the superior image quality clinicians have come to expect from Hologic products, helping to streamline workflows and reduce recalls while decreasing procedure times,” said Pete Valenti, Hologic’s Division President, Breast and Skeletal Health Solutions. Prior mammography or biopsy images can be displayed on the same Trident HD high-resolution monitor to speed comparison and analysis, resulting in reduced procedure time and improved workflow.1 Additionally, an intuitive touchscreen interface and wireless integration supports advanced image sharing and seamless transfer of patient records to the facility’s picture archiving and communication system (PACS).

Read Full Details

Topics:
  • Business
  • Health
  • Technology
  • Science

Tuesday, April 23


News

Hologic’s Cynosure Division Announces Brooke Shields as Celebrity Spokesperson for SculpSure® Body Contouring

HOLX

Hologic’s (Nasdaq: HOLX) Cynosure division announced today that iconic actress, model, Broadway star and author Brooke Shields will serve as national spokesperson for the state-of-the-art SculpSure® body contouring laser treatment. As the face of SculpSure’s new “Be strong. SculpSure body contouring is an FDA-cleared, non-invasive, light-based treatment that safely and effectively targets and permanently destroys fat cells in the treated area, helping women and men achieve a slimmer appearance. I chose SculpSure treatments because I was looking for a body contouring option that complements the hard work I put in every day, and I want to inspire others to feel beautiful and confident.”. Consumers who visit SculpSure.com and upload a photo of themselves and share how a SculpSure treatment will improve their self-confidence will have a chance to win two free SculpSure treatments and a trip to New York City.

Read Full Details

Topics:
  • Business
  • Health
  • Technology
  • Science

Tuesday, April 16


News

Hologic's Diagnostics Grows Strong, Escalating Costs a Woe

HOLX

The company’s progress in the domestic and international markets plus a strong pipeline of products and a solid performance delivered by its GYN Surgical and Molecular Diagnostics segments bolster our confidence. However, the company continues to struggle with tough competition, particularly in the tomosynthesis market. We are also upbeat about the recent product launches like the Omni hysteroscope and Panther Fusion Open Access functionality in the United States, the Panther Fusion Bordetella assay in Europe and the Surgical hand piece for the TempSure radiofrequency system in North America. Management is impressed by a steady growth rate in the core molecular diagnostics sub-segment, which accounted for roughly 55.4% of its total Diagnostics revenues in the first quarter of fiscal 2019. Click to get this free report Varian Medical Systems, Inc. (VAR) : Free Stock Analysis Report Penumbra, Inc. (PEN) : Free Stock Analysis Report Hologic, Inc. (HOLX) : Free Stock Analysis Report Amedisys, Inc. (AMED) : Free Stock Analysis Report To read this article on Zacks.com click here.

Read Full Details

Topics:
  • Business
  • Financial

Friday, April 12


News

Osterweis Capital Management INC Decreased Hologic INC (HOLX) Stake as Shares Rose

HOLX

Investors holded 259.62 million in 2018Q3 but now own 257.56 million shares or 0.80% less. Plante Moran Finance Advsr Limited Liability Company reported 0% in Hologic, Inc. (NASDAQ:HOLX). Td Asset Mgmt Incorporated owns 863,853 shs for 0.06% of their capital. $13.86B is the MC of Hologic Inc. Ticker’s shares touched $47.58 during the last trading session after 0.40% change.Hologic, Inc. has volume of 463,205 shares. Since April 12, 2018 HOLX has risen 24.82% and is uptrending.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, April 10


News

On May, 1 Analysts See $0.56 EPS for Hologic, Inc. (HOLX)

HOLX

On May, 1 Analysts See $0.56 EPS for Hologic, Inc. (HOLX). The ratio improved due to Hologic, Inc. positioning: 32 sold and 142 reduced. Bank & Trust Of Ny Mellon Corp stated it has 0.02% of its capital in Hologic, Inc. (NASDAQ:HOLX). That is 5.66 % up compareed to $0.53 EPS for last year. If EPS of $0.56 is published the profit of HOLX could be $163.13 million giving it 21.23 P/E.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, April 09


News

Hologic INC (HOLX) Stake Decreased by Osterweis Capital Management Inc

HOLX

Hartford Invest Management Comm holds 30,088 shs or 0.04% of its capital. On Wednesday, November 28 $589,950 worth of Hologic, Inc. (NASDAQ:HOLX) was sold by Stamoulis Christiana. $13.70 billion is the market cap of Hologic Inc. HOLX is reaching $47.04 during the last trading session, after increased 0.49%.Currently Hologic, Inc. is uptrending after 24.82% change in last April 9, 2018. Osterweis Capital Management Inc has risen its stake in Antero Midstream Gp Lp and also increased its holding in Quinstreet Inc (NASDAQ:QNST) by 293,350 shares in the quarter, for a total of 593,971 shares.

Read Full Details

Topics:
  • Business
  • Financial

Sunday, April 07


News

Hologic INC (HOLX) Valuation Rose While Osterweis Capital Management INC Decreased Stake by $6.61 Million

HOLX

257.56 million shares or 0.80% less from 259.62 million shares in 2018Q3 were reported. Moody Comml Bank Trust Division reported 0.03% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Osterweis Capital Management Inc, which manages about $1.62B and $1.30B US Long portfolio, upped its stake in Avalara Inc by 97,470 shares to 235,755 shares, valued at $7.34M in 2018Q4, according to the filing. More notable recent Hologic, Inc. (NASDAQ:HOLX) news were published by: Nasdaq.com which released: “Interesting HOLX Put And Call Options For May 17th – Nasdaq” on March 20, 2019, also Streetinsider.com with their article: “Hologic (HOLX) Applauds FDA’s Proposed Rule to Update Mammography Regulations Issued Under the Mammography Quality Standards Act – StreetInsider.com” published on March 29, 2019, Nasdaq.com published: “Here’s Why You Should Invest in ResMed (RMD) Stock Right Now – Nasdaq” on April 01, 2019.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, April 06


News

Hologic INC (HOLX) Shares Rose While Osterweis Capital Management INC Decreased Stake by $6.61 Million

HOLX

Investors holded 259.62 million in 2018Q3 but now own 257.56 million shares or 0.80% less. Moreover, Ubs Asset Management Americas Incorporated has 0% invested in Hologic, Inc. (NASDAQ:HOLX) for 980,452 shs. $13.73B is the market cap of Hologic Inc. HOLX is hitting $47.13 during the last trading session, after decreased 0.38%.Hologic, Inc. has volume of 1.68 million shares. Since April 6, 2018 HOLX has risen 24.82% and is uptrending. The Osterweis Capital Management Inc’s stake in Ligand Pharmaceuticals Inc (NASDAQ:LGND) was rose by 26,440 shares to 55,974 shares valued at $7.60M in 2018Q4, according to the filing.

Read Full Details

Topics:
  • Business
  • Financial

Friday, April 05


News

As Hologic INC (HOLX) Shares Rose, Parnassus Investments Decreased Its Stake by $32.67 Million

HOLX

The ratio increased due to HOLX positioning: 32 sold and 142 reduced. Investors holded 259.62 million in 2018Q3 but now own 257.56 million shares or 0.80% less. Hsbc Holding Public Limited Liability Co holds 0.01% in Hologic, Inc. (NASDAQ:HOLX) or 157,618 shs. Northern Corp holds 3.21M shs or 0.04% of its capital. Moreover, Boston Family Office has 0.24% invested in Hologic, Inc. (NASDAQ:HOLX). North Star Mgmt owns 400 shs or 0% of their US capital.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, April 03


News

As Hologic INC (HOLX) Market Valuation Rose, Holder Osterweis Capital Management INC Cut by $6.61 Million Its Stake

HOLX

It is positive, as 32 investors sold HOLX shares while 142 reduced holdings. Hartford Inv Mgmt Co owns 30,088 shares for 0.04% of their portfolio. Since November 5, 2018, it had 0 buys, and 7 sales for $2.18 million activity. On Friday, December 7 Valenti Peter J. III sold $200,028 worth of Hologic, Inc. (NASDAQ:HOLX) or 4,740 shares. More notable recent Hologic, Inc. (NASDAQ:HOLX) news were published by: Seekingalpha.com which released: “Hologic FQ1 top line up 5%; guidance raised – Seeking Alpha” on January 30, 2019, also Globenewswire.com with their article: “New Research: Key Drivers of Growth for Marsh & McLennan Companies, Conagra Brands, Amgen, Emerson Electric, Polaris Industries, and Hologic — Factors of Influence, Major Initiatives and Sustained Production – GlobeNewswire” published on March 05, 2019, Nasdaq.com published: “HOLX vs DXCM: Which MedTech Stock is a Better Investment Pick?

Read Full Details

Topics:
  • Business
  • Financial